Tower Research Capital LLC (Trc) Cassava Sciences Inc Transaction History

Tower Research Capital LLC (Trc)

$3.39 Billion
Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Cassava Sciences Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,423 shares of SAVA stock, worth $14,967. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,423

Previous 13,029 58.38%

Holding current value

$14,967

Previous $23,000 34.78%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$1.85 - $3.41 $14,071 - $25,936	-7,606 Reduced 58.38%	5,423 $15,000
Q2 2025 Aug 14, 2025	BUY	$1.19 - $2.24 $7,695 - $14,486	6,467 Added 98.55%	13,029 $23,000
Q1 2025 May 15, 2025	BUY	$1.5 - $3.02 $22 - $45	15 Added 0.23%	6,562 $9,000
Q4 2024 Feb 13, 2025	BUY	$2.29 - $32.18 $769 - $10,812	336 Added 5.41%	6,547 $15,000
Q3 2024 Nov 14, 2024	SELL	$9.57 - $35.08 $55,984 - $205,218	-5,850 Reduced 48.5%	6,211 $182,000

Q2 2024 Aug 13, 2024	BUY	$12.35 - $26.11 $136,257 - $288,071	11,033 Added 1073.25%	12,061 $148,000
Q1 2024 May 15, 2024	SELL	$18.44 - $26.41 $137,746 - $197,282	-7,470 Reduced 87.9%	1,028 $20,000
Q4 2023 Feb 13, 2024	BUY	$12.64 - $30.11 $83,461 - $198,816	6,603 Added 348.44%	8,498 $191,000
Q3 2023 Nov 14, 2023	SELL	$16.64 - $25.32 $17,971 - $27,345	-1,080 Reduced 36.3%	1,895 $31,000
Q2 2023 Aug 14, 2023	SELL	$21.59 - $27.88 $53,068 - $68,529	-2,458 Reduced 45.24%	2,975 $72,000
Q1 2023 May 09, 2023	BUY	$23.46 - $36.44 $91,306 - $141,824	3,892 Added 252.56%	5,433 $131,000
Q4 2022 Feb 10, 2023	BUY	$27.82 - $44.16 $5,202 - $8,257	187 Added 13.81%	1,541 $45,000
Q3 2022 Nov 10, 2022	SELL	$16.33 - $51.06 $139,670 - $436,716	-8,553 Reduced 86.33%	1,354 $56,000
Q2 2022 Aug 15, 2022	BUY	$17.22 - $38.47 $129,683 - $289,717	7,531 Added 316.96%	9,907 $278,000
Q1 2022 May 12, 2022	BUY	$32.6 - $53.05 $13,855 - $22,546	425 Added 21.78%	2,376 $88,000
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $4,927 - $12,181	134 Added 7.37%	1,951 $85,000
Q3 2021 Nov 15, 2021	SELL	$41.79 - $135.3 $231,809 - $750,509	-5,547 Reduced 75.33%	1,817 $113,000
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $155,895 - $435,052	4,849 Added 192.8%	7,364 $629,000
Q1 2021 May 17, 2021	SELL	$7.09 - $87.95 $6,324 - $78,451	-892 Reduced 26.18%	2,515 $113,000
Q4 2020 Feb 16, 2021	SELL	$6.79 - $12.25 $129,729 - $234,048	-19,106 Reduced 84.87%	3,407 $23,000
Q3 2020 Nov 16, 2020	BUY	$2.86 - $11.51 $61,095 - $245,876	21,362 Added 1855.95%	22,513 $259,000
Q2 2020 Aug 13, 2020	SELL	$2.04 - $9.64 $1,423 - $6,728	-698 Reduced 37.75%	1,151 $4,000
Q1 2020 May 15, 2020	BUY	$3.26 - $9.65 $6,027 - $17,842	1,849 New	1,849 $8,000

Others Institutions Holding SAVA

# of Institutions

135

Shares Held

15.9M

Call Options Held

1.26M

Put Options Held

791K

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $111M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Cassava Sciences Inc Transaction History